Literature DB >> 21934601

Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment.

Filip Yves De Vos1, Willem Joost Lesterhuis, Roger Johannes Brüggemann, Winette Tita van der Graaf.   

Abstract

A patient with metastatic ovarian cancer was treated with liposomal doxorubicin and carboplatin. She had an extravasation during liposomal doxorubicin infusion. Initially, she was treated conservatively with cold compresses and topical treatment. However, because of worsening of symptoms, she received dexrazoxane once daily for 3 days after which complete recovery occurred. This is the first casereport on symptomatic extravasation of liposomal doxorubicin treated with dexrazoxane.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21934601     DOI: 10.1097/CAD.0b013e32834be51a

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

Review 1.  Treatment of anthracycline extravasations using dexrazoxane.

Authors:  D Conde-Estévez; J Mateu-de Antonio
Journal:  Clin Transl Oncol       Date:  2013-08-15       Impact factor: 3.405

2.  Development and Validation of New RP-HPLC Method for the Determination of Dexrazoxane.

Authors:  M V Basaveswara Rao; V Prasanthi; G Venkata Rao; B V Raman
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.